News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ajinomoto And Astellas Pharma Inc. Jointly File Application Seeking Additional Approval For Combination Therapy Of FASTIC/STARSIS Tablets


1/31/2006 1:01:44 PM

Tokyo, Jan 31, 2006 (JCN) - Ajinomoto and Astellas Pharma jointly announced on January 27 that they have filed a supplemental New Drug Application (SNDA) for FASTIC Tablet/STARSIS Tablet (nateglinide), a fast-acting postprandial hypoglycemic agent co-developed by the two companies.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES